#BRCtenantNews congratulations to @AblatusL for achieving its first CE mark for a component in its Bimodal Electric Tissue Ablation system. Details: https://t.co/jP8ziN4aFD
#BRCtenantNews@AblatusL has achieved ISO 13485 - the global standard in quality management systems for medical devices - following successful audits with BSI. Details: https://t.co/NlqninJKO9
#BRCtenantNews Congratulations to @AblatusL for achieving ISO 13485 - the global standard in quality management systems for medical devices - following successful audits with BSI. Details: https://t.co/wV7asDeDTU
#BRCtenantNews@AblatusL did a sterling job to make the top five in the @techcorridoruk East of England Investment Catalyst final. Full story: https://t.co/80o1PrPM7N
Ablatus Therapeutics CEO, David Brooks pitched to investors at Minerva Business Angel Network yesterday evening at The Shard, London. Such an interesting range of businesses pitching. A thoroughly good evening. @MinervaAngels #angelinvestment#medtech
With its' revolutionary ablation tech, East of England Investment Catalyst finalist @AblatusL is ready to transform medical treatment. Investors can meet Ablatus at the Investment Catalyst Grand Final in London on November 26 - for tickets DM or email [email protected]
We made it to the final of the East of England Investment Catalyst Pitching Day! Brilliant work by our CEO David Brooks https://t.co/FA9HFcKI9c #MedTech#investment